ATE348149T1 - Isolated islets, comprising insulin producing cells, coated with heparin - Google Patents
Isolated islets, comprising insulin producing cells, coated with heparinInfo
- Publication number
- ATE348149T1 ATE348149T1 AT00906843T AT00906843T ATE348149T1 AT E348149 T1 ATE348149 T1 AT E348149T1 AT 00906843 T AT00906843 T AT 00906843T AT 00906843 T AT00906843 T AT 00906843T AT E348149 T1 ATE348149 T1 AT E348149T1
- Authority
- AT
- Austria
- Prior art keywords
- producing cells
- heparin
- coated
- insulin producing
- isolated islets
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title abstract 4
- 102000004877 Insulin Human genes 0.000 title abstract 2
- 108090001061 Insulin Proteins 0.000 title abstract 2
- 229940125396 insulin Drugs 0.000 title abstract 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 title 1
- 229960002897 heparin Drugs 0.000 title 1
- 229920000669 heparin Polymers 0.000 title 1
- 238000002054 transplantation Methods 0.000 abstract 3
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 abstract 2
- 206010053567 Coagulopathies Diseases 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000035602 clotting Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 210000004153 islets of langerhan Anatomy 0.000 abstract 1
- 238000001356 surgical procedure Methods 0.000 abstract 1
- 208000035408 type 1 diabetes mellitus 1 Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9900398A SE523817C2 (sv) | 1999-02-05 | 1999-02-05 | Användning av ett koagulationsförebyggande ämne i samband med transplantation av insulinproducerande celler |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE348149T1 true ATE348149T1 (de) | 2007-01-15 |
Family
ID=20414376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00906843T ATE348149T1 (de) | 1999-02-05 | 2000-02-04 | Isolated islets, comprising insulin producing cells, coated with heparin |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7981873B1 (de) |
| EP (1) | EP1171156B1 (de) |
| JP (1) | JP2003501346A (de) |
| AT (1) | ATE348149T1 (de) |
| AU (1) | AU769063B2 (de) |
| CA (1) | CA2361949C (de) |
| DE (1) | DE60032346T2 (de) |
| SE (1) | SE523817C2 (de) |
| WO (1) | WO2000045837A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0200198D0 (sv) | 2002-01-23 | 2002-01-23 | Astrazeneca Ab | New use |
| WO2004084930A1 (en) * | 2003-03-26 | 2004-10-07 | Develogen Aktiengesellschaft | Use of saposin-related proteins for preventing and treating obesity, diabetes and/or metabolic syndrome |
| CA2612621C (en) * | 2005-07-01 | 2014-11-18 | Corline Systems Ab | Heparin coating of biological tissue |
| SE530716C2 (sv) | 2006-10-06 | 2008-08-19 | Corline Systems Ab | Molekylärt aggregat på ett substrat |
| EP2550004A4 (de) * | 2010-03-12 | 2014-07-02 | Univ Australian | Heparansulfatersatztherapie |
| US9795629B2 (en) | 2011-12-22 | 2017-10-24 | Corline Systems Ab | Aqueous solution comprising a macromolecular conjugate of heparin for the treatment of blood vessels |
| WO2017149391A1 (en) * | 2016-03-02 | 2017-09-08 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | The use of antithrombin for coating organs during transplantation |
| CN120957766A (zh) | 2023-03-30 | 2025-11-14 | 科林生物医学公司 | 肝素官能化表面及其制备和用途 |
| EP4688028A1 (de) | 2023-03-30 | 2026-02-11 | Corline Biomedical AB | Verfahren zur bereitstellung einer verbesserten heparinfunktionalisierten oberfläche |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5135916A (en) | 1989-06-12 | 1992-08-04 | Oklahoma Medical Research Foundation | Inhibition of complement mediated inflammatory response |
| DE495852T1 (de) | 1989-10-12 | 1994-03-31 | Imutran Ltd | Modifiziertes biologisches material. |
| WO1993023085A1 (en) | 1992-05-21 | 1993-11-25 | Diatech, Inc. | TECHNETIUM-99m LABELED PEPTIDES FOR THROMBUS IMAGING |
| SE470006B (sv) | 1991-09-26 | 1993-10-25 | Corline Systems Ab | Nytt konjugat, dess framställning och användning samt substrat preparerat med konjugatet |
| WO1993009176A2 (en) * | 1991-10-29 | 1993-05-13 | Clover Consolidated, Limited | Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release |
| JP2000500121A (ja) | 1995-09-27 | 2000-01-11 | エモリー・ユニバーシティー | 免疫系による生きた被移植細胞の破壊を阻止する方法 |
| DE19623440A1 (de) * | 1996-06-12 | 1997-12-18 | Wagner Karl Heinz Dr Med | Immobilisiertes organisches Material mit definiertem Wirkstoff-Release |
| JP4243355B2 (ja) | 1997-03-26 | 2009-03-25 | インペリアル カレッジ イノベイションズ リミテッド | 細胞膜に固定された抗凝固性融合タンパク質 |
-
1999
- 1999-02-05 SE SE9900398A patent/SE523817C2/sv not_active IP Right Cessation
-
2000
- 2000-02-04 AT AT00906843T patent/ATE348149T1/de not_active IP Right Cessation
- 2000-02-04 CA CA2361949A patent/CA2361949C/en not_active Expired - Fee Related
- 2000-02-04 EP EP00906843A patent/EP1171156B1/de not_active Expired - Lifetime
- 2000-02-04 JP JP2000596956A patent/JP2003501346A/ja active Pending
- 2000-02-04 US US09/890,936 patent/US7981873B1/en not_active Expired - Fee Related
- 2000-02-04 DE DE60032346T patent/DE60032346T2/de not_active Expired - Lifetime
- 2000-02-04 WO PCT/SE2000/000223 patent/WO2000045837A1/en not_active Ceased
- 2000-02-04 AU AU28399/00A patent/AU769063B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CA2361949C (en) | 2010-08-03 |
| SE9900398L (sv) | 2000-08-06 |
| EP1171156B1 (de) | 2006-12-13 |
| CA2361949A1 (en) | 2000-08-10 |
| AU769063B2 (en) | 2004-01-15 |
| AU2839900A (en) | 2000-08-25 |
| DE60032346D1 (en) | 2007-01-25 |
| SE523817C2 (sv) | 2004-05-18 |
| SE9900398D0 (sv) | 1999-02-05 |
| US7981873B1 (en) | 2011-07-19 |
| JP2003501346A (ja) | 2003-01-14 |
| WO2000045837A1 (en) | 2000-08-10 |
| EP1171156A1 (de) | 2002-01-16 |
| DE60032346T2 (de) | 2007-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Liu et al. | Skin‐inspired and self‐regulated hydrophobic hydrogel for diabetic wound therapy | |
| CN105979975A (zh) | 医疗敷料 | |
| Liang et al. | Lipid rescue of massive verapamil overdose: a case report | |
| MX2007004769A (es) | Derivado de pirimidina condensado con un anillo no aromatico. | |
| WO2009023718A3 (en) | Novel activators of glucokinase | |
| BR9906813A (pt) | Método para administração de insulina aspb28- humana | |
| ATE348149T1 (de) | Isolated islets, comprising insulin producing cells, coated with heparin | |
| IT9048057A1 (it) | Impiego di uridina nel trattamento farmacologico delle complicazioni periferiche del diabete | |
| JPS61194020A (ja) | 網膜症治療剤 | |
| John et al. | Bradycardia associated with steroid use for laryngeal edema in an adult: a case report and literature review | |
| BR0306798A (pt) | Uso de melagatran ou de um derivado farmaceuticamente aceitável deste, métodos de tratamento de diabetes mellitus tipo i, de transplante de células de enxertamento de ilhotas de langerhans, para melhorar a independência de insulina em pacientes com diabetes mellitus tipo i, e de tratamento de reação inflamatória mediada pelo sangue instantânea, formulação farmacêutica para uso no tratamento de diabetes mellitus tipo i, kit de partes, e, método de fabricação de um kit de partes. | |
| CA2593171A1 (en) | Pharmaceutical composition and method for neoangiogenesis/revascularization useful in treating ischemic heart diseases | |
| Krishnan et al. | Materials approaches for next-generation encapsulated cell therapies | |
| Toprak et al. | Anaesthetic management of severe bradycardia during general anaesthesia using temporary cardiac pacing | |
| CO5611170A2 (es) | Uso de un inhibidor antagonista contra el factor tisular | |
| CN109010350B (zh) | 长梗冬青苷在制备抗糖尿病皮肤溃疡药物中的应用 | |
| El Houari et al. | A survival case in a severe amlodipine intoxication | |
| DE60210774D1 (de) | Mineral-protein enthaltende zusammensetzungen und diabetische neuropathien | |
| CN206434601U (zh) | 一种新型辣椒碱水凝胶贴剂 | |
| CN101474178A (zh) | 盐酸戊乙奎醚在制备治疗心源性休克疾病药物中的应用 | |
| CN102068441A (zh) | 一种含有替米沙坦和格列美脲的复方制剂 | |
| CN103816131A (zh) | 氟比洛芬双层渗透泵控释片及其制备方法 | |
| Livshits et al. | Hypotension and Seizure in a Healthy Young Woman | |
| KR20170028566A (ko) | 약물을 봉입한 이식 치료용 세포 클러스터 및 이의 제조방법 | |
| SE0103749D0 (sv) | Treatment of congestive heart failure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |